Literature DB >> 17308018

Histological evaluation of the adrenal glands of seven dogs with hyperadrenocorticism treated with trilostane.

C E Reusch1, N Sieber-Ruckstuhl, M Wenger, H Lutz, A Perren, A Pospischil.   

Abstract

The lesions in the adrenal glands of seven dogs with hyperadrenocorticism that had been treated with trilostane were studied histologically. The glands of the six dogs with pituitary-dependent hyperadrenocorticism had moderate to severe cortical hyperplasia that was either diffuse or nodular. The lesions were more pronounced in the zona fasciculata than in the zona reticularis, and the zona glomerulosa was normal. In the dog with a functional adrenal tumour the non-tumour bearing adrenal gland showed mild nodular hyperplasia. Five of the seven dogs had variable degrees of adrenal necrosis, which was severe in two of them. The terminal deoxynucleotidyl transferase-mediated DUTP nick-end labelling (TUNEL) reaction specified areas of cell death as apoptosis in three of the dogs, and was positive in one of the dogs without visible areas of cell death. There were variable degrees of cortical haemorrhage in three of the dogs. In some of the dogs the lesions were severe enough to lead to hypoadrenocorticism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17308018     DOI: 10.1136/vr.160.7.219

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  5 in total

Review 1.  Canine hypoadrenocorticism: part I.

Authors:  Susan C Klein; Mark E Peterson
Journal:  Can Vet J       Date:  2010-01       Impact factor: 1.008

Review 2.  Update on the use of trilostane in dogs.

Authors:  Julie Lemetayer; Shauna Blois
Journal:  Can Vet J       Date:  2018-04       Impact factor: 1.008

3.  Effect of trilostane and mitotane on aldosterone secretory reserve in dogs with pituitary-dependent hyperadrenocorticism.

Authors:  L E Reid; E N Behrend; L G Martin; R J Kemppainen; C R Ward; J C Lurye; T C Donovan; H P Lee
Journal:  J Vet Intern Med       Date:  2014-01-08       Impact factor: 3.333

4.  Comparison of 2 Doses for ACTH Stimulation Testing in Dogs Suspected of or Treated for Hyperadrenocorticism.

Authors:  C Aldridge; E N Behrend; R J Kemppainen; T M Lee-Fowler; L G Martin; C R Ward; D Bruyette; J Pannu; P Gaillard; H P Lee
Journal:  J Vet Intern Med       Date:  2016-07-18       Impact factor: 3.333

5.  Melanocortin 2 receptor antagonists in canine pituitary-dependent hypercortisolism: in vitro studies.

Authors:  Karin Sanders; Jan A Mol; Hans S Kooistra; Sara Galac
Journal:  Vet Res Commun       Date:  2018-09-05       Impact factor: 2.459

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.